Last $3.98 USD
Change Today +0.12 / 3.11%
Volume 4.7K
TLOG On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark A. McKinlay Ph.D.

AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 3 different industries.

See Board Relationships
62--

Background*

Dr. Mark A. McKinlay, Ph.D. founded TetraLogic Pharmaceuticals, Inc. (formerly, Gentara Corporation) in 2003 and served as its Chief Scientific Officer and Senior Vice President of Research & Development. Dr. McKinlay founded and served as Vice President of Research and Development of ViroPharma Inc. from December 1994 to April 2004. Dr. McKinlay served as Secretary of Viropharma Inc. from December 1994 to February 1997. From 1989 to 1994, Dr. McKinlay held a variety ...

Read Full Background

Corporate Headquarters*

343 Phoenixville Pike
Malvern, Pennsylvania 19355

United States

Phone: 610-889-9900
Fax: 610-889-9994

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1978
Rensselaer Polytechnic Institute

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TLOG:US $3.98 USD +0.12

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TETRALOGIC PHARMACEUTICALS C, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.